GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ChemoMetec AS (LTS:0DZ0) » Definitions » EV-to-FCF

ChemoMetec AS (LTS:0DZ0) EV-to-FCF : 59.22 (As of Apr. 11, 2025)


View and export this data going back to 2007. Start your Free Trial

What is ChemoMetec AS EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ChemoMetec AS's Enterprise Value is kr7,591.6 Mil. ChemoMetec AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr128.2 Mil. Therefore, ChemoMetec AS's EV-to-FCF for today is 59.22.

The historical rank and industry rank for ChemoMetec AS's EV-to-FCF or its related term are showing as below:

LTS:0DZ0' s EV-to-FCF Range Over the Past 10 Years
Min: -1196.48   Med: 92.2   Max: 306.54
Current: 53.9

During the past 13 years, the highest EV-to-FCF of ChemoMetec AS was 306.54. The lowest was -1196.48. And the median was 92.20.

LTS:0DZ0's EV-to-FCF is ranked worse than
78.04% of 387 companies
in the Medical Devices & Instruments industry
Industry Median: 22.93 vs LTS:0DZ0: 53.90

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-11), ChemoMetec AS's stock price is kr458.30. ChemoMetec AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr9.720. Therefore, ChemoMetec AS's PE Ratio (TTM) for today is 47.15.


ChemoMetec AS EV-to-FCF Historical Data

The historical data trend for ChemoMetec AS's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChemoMetec AS EV-to-FCF Chart

ChemoMetec AS Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 118.97 174.48 107.25 68.82 58.60

ChemoMetec AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 68.82 - 58.60 -

Competitive Comparison of ChemoMetec AS's EV-to-FCF

For the Medical Devices subindustry, ChemoMetec AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChemoMetec AS's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's EV-to-FCF falls into.


;
;

ChemoMetec AS EV-to-FCF Calculation

ChemoMetec AS's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=7591.559/128.193
=59.22

ChemoMetec AS's current Enterprise Value is kr7,591.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr128.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChemoMetec AS  (LTS:0DZ0) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ChemoMetec AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=458.30/9.720
=47.15

ChemoMetec AS's share price for today is kr458.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ChemoMetec AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr9.720.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ChemoMetec AS EV-to-FCF Related Terms

Thank you for viewing the detailed overview of ChemoMetec AS's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


ChemoMetec AS Business Description

Traded in Other Exchanges
Address
Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.

ChemoMetec AS Headlines

No Headlines